Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis

Wantae Kim, Sanjoy Kumar Khan, Jelena Gvozdenovic-Jeremic, Youngeun Kim, Jason Dahlman, Hanjun Kim, Ogyi Park, Tohru Ishitani, Eek Hoon Jho, Bin Gao, Yingzi Yang

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Malignant tumors develop through multiple steps of initiation and progression, and tumor initiation is of singular importance in tumor prevention, diagnosis, and treatment. However, the molecular mechanism whereby a signaling network of interacting pathways restrains proliferation in normal cells and prevents tumor initiation is still poorly understood. Here, we have reported that the Hippo, Wnt/β-catenin, and Notch pathways form an interacting network to maintain liver size and suppress hepatocellular carcinoma (HCC). Ablation of the mammalian Hippo kinases Mst1 and Mst2 in liver led to rapid HCC formation and activated Yes-associated protein/WW domain containing transcription regulator 1 (YAP/TAZ), STAT3, Wnt/β-catenin, and Notch signaling. Previous work has shown that abnormal activation of these downstream pathways can lead to HCC. Rigorous genetic experiments revealed that Notch signaling forms a positive feedback loop with the Hippo signaling effector YAP/TAZ to promote severe hepatomegaly and rapid HCC initiation and progression. Surprisingly, we found that Wnt/β- catenin signaling activation suppressed HCC formation by inhibiting the positive feedback loop between YAP/TAZ and Notch signaling. Furthermore, we found that STAT3 in hepatocytes is dispensable for HCC formation when mammalian sterile 20-like kinase 1 and 2 (Mst1 and Mst2) were removed. The molecular network we have identified provides insights into HCC molecular classifications and therapeutic developments for the treatment of liver tumors caused by distinct genetic mutations.

Original languageEnglish
Pages (from-to)137-152
Number of pages16
JournalJournal of Clinical Investigation
Volume127
Issue number1
DOIs
Publication statusPublished - Jan 3 2017

Fingerprint

Catenins
Hepatocellular Carcinoma
Carcinogenesis
Liver
Neoplasms
Phosphotransferases
Hepatomegaly
Hepatocytes
Mutation

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Kim, W., Khan, S. K., Gvozdenovic-Jeremic, J., Kim, Y., Dahlman, J., Kim, H., ... Yang, Y. (2017). Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis. Journal of Clinical Investigation, 127(1), 137-152. https://doi.org/10.1172/JCI88486

Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis. / Kim, Wantae; Khan, Sanjoy Kumar; Gvozdenovic-Jeremic, Jelena; Kim, Youngeun; Dahlman, Jason; Kim, Hanjun; Park, Ogyi; Ishitani, Tohru; Jho, Eek Hoon; Gao, Bin; Yang, Yingzi.

In: Journal of Clinical Investigation, Vol. 127, No. 1, 03.01.2017, p. 137-152.

Research output: Contribution to journalArticle

Kim, W, Khan, SK, Gvozdenovic-Jeremic, J, Kim, Y, Dahlman, J, Kim, H, Park, O, Ishitani, T, Jho, EH, Gao, B & Yang, Y 2017, 'Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis', Journal of Clinical Investigation, vol. 127, no. 1, pp. 137-152. https://doi.org/10.1172/JCI88486
Kim, Wantae ; Khan, Sanjoy Kumar ; Gvozdenovic-Jeremic, Jelena ; Kim, Youngeun ; Dahlman, Jason ; Kim, Hanjun ; Park, Ogyi ; Ishitani, Tohru ; Jho, Eek Hoon ; Gao, Bin ; Yang, Yingzi. / Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis. In: Journal of Clinical Investigation. 2017 ; Vol. 127, No. 1. pp. 137-152.
@article{a72033f037144f4ebf29f80e614683e9,
title = "Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis",
abstract = "Malignant tumors develop through multiple steps of initiation and progression, and tumor initiation is of singular importance in tumor prevention, diagnosis, and treatment. However, the molecular mechanism whereby a signaling network of interacting pathways restrains proliferation in normal cells and prevents tumor initiation is still poorly understood. Here, we have reported that the Hippo, Wnt/β-catenin, and Notch pathways form an interacting network to maintain liver size and suppress hepatocellular carcinoma (HCC). Ablation of the mammalian Hippo kinases Mst1 and Mst2 in liver led to rapid HCC formation and activated Yes-associated protein/WW domain containing transcription regulator 1 (YAP/TAZ), STAT3, Wnt/β-catenin, and Notch signaling. Previous work has shown that abnormal activation of these downstream pathways can lead to HCC. Rigorous genetic experiments revealed that Notch signaling forms a positive feedback loop with the Hippo signaling effector YAP/TAZ to promote severe hepatomegaly and rapid HCC initiation and progression. Surprisingly, we found that Wnt/β- catenin signaling activation suppressed HCC formation by inhibiting the positive feedback loop between YAP/TAZ and Notch signaling. Furthermore, we found that STAT3 in hepatocytes is dispensable for HCC formation when mammalian sterile 20-like kinase 1 and 2 (Mst1 and Mst2) were removed. The molecular network we have identified provides insights into HCC molecular classifications and therapeutic developments for the treatment of liver tumors caused by distinct genetic mutations.",
author = "Wantae Kim and Khan, {Sanjoy Kumar} and Jelena Gvozdenovic-Jeremic and Youngeun Kim and Jason Dahlman and Hanjun Kim and Ogyi Park and Tohru Ishitani and Jho, {Eek Hoon} and Bin Gao and Yingzi Yang",
year = "2017",
month = "1",
day = "3",
doi = "10.1172/JCI88486",
language = "English",
volume = "127",
pages = "137--152",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "1",

}

TY - JOUR

T1 - Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis

AU - Kim, Wantae

AU - Khan, Sanjoy Kumar

AU - Gvozdenovic-Jeremic, Jelena

AU - Kim, Youngeun

AU - Dahlman, Jason

AU - Kim, Hanjun

AU - Park, Ogyi

AU - Ishitani, Tohru

AU - Jho, Eek Hoon

AU - Gao, Bin

AU - Yang, Yingzi

PY - 2017/1/3

Y1 - 2017/1/3

N2 - Malignant tumors develop through multiple steps of initiation and progression, and tumor initiation is of singular importance in tumor prevention, diagnosis, and treatment. However, the molecular mechanism whereby a signaling network of interacting pathways restrains proliferation in normal cells and prevents tumor initiation is still poorly understood. Here, we have reported that the Hippo, Wnt/β-catenin, and Notch pathways form an interacting network to maintain liver size and suppress hepatocellular carcinoma (HCC). Ablation of the mammalian Hippo kinases Mst1 and Mst2 in liver led to rapid HCC formation and activated Yes-associated protein/WW domain containing transcription regulator 1 (YAP/TAZ), STAT3, Wnt/β-catenin, and Notch signaling. Previous work has shown that abnormal activation of these downstream pathways can lead to HCC. Rigorous genetic experiments revealed that Notch signaling forms a positive feedback loop with the Hippo signaling effector YAP/TAZ to promote severe hepatomegaly and rapid HCC initiation and progression. Surprisingly, we found that Wnt/β- catenin signaling activation suppressed HCC formation by inhibiting the positive feedback loop between YAP/TAZ and Notch signaling. Furthermore, we found that STAT3 in hepatocytes is dispensable for HCC formation when mammalian sterile 20-like kinase 1 and 2 (Mst1 and Mst2) were removed. The molecular network we have identified provides insights into HCC molecular classifications and therapeutic developments for the treatment of liver tumors caused by distinct genetic mutations.

AB - Malignant tumors develop through multiple steps of initiation and progression, and tumor initiation is of singular importance in tumor prevention, diagnosis, and treatment. However, the molecular mechanism whereby a signaling network of interacting pathways restrains proliferation in normal cells and prevents tumor initiation is still poorly understood. Here, we have reported that the Hippo, Wnt/β-catenin, and Notch pathways form an interacting network to maintain liver size and suppress hepatocellular carcinoma (HCC). Ablation of the mammalian Hippo kinases Mst1 and Mst2 in liver led to rapid HCC formation and activated Yes-associated protein/WW domain containing transcription regulator 1 (YAP/TAZ), STAT3, Wnt/β-catenin, and Notch signaling. Previous work has shown that abnormal activation of these downstream pathways can lead to HCC. Rigorous genetic experiments revealed that Notch signaling forms a positive feedback loop with the Hippo signaling effector YAP/TAZ to promote severe hepatomegaly and rapid HCC initiation and progression. Surprisingly, we found that Wnt/β- catenin signaling activation suppressed HCC formation by inhibiting the positive feedback loop between YAP/TAZ and Notch signaling. Furthermore, we found that STAT3 in hepatocytes is dispensable for HCC formation when mammalian sterile 20-like kinase 1 and 2 (Mst1 and Mst2) were removed. The molecular network we have identified provides insights into HCC molecular classifications and therapeutic developments for the treatment of liver tumors caused by distinct genetic mutations.

UR - http://www.scopus.com/inward/record.url?scp=85008392800&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85008392800&partnerID=8YFLogxK

U2 - 10.1172/JCI88486

DO - 10.1172/JCI88486

M3 - Article

AN - SCOPUS:85008392800

VL - 127

SP - 137

EP - 152

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 1

ER -